Literature DB >> 11408389

Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats.

R C Tambascia1, P M Fonseca, P D Corat, H Moreno, M J Saad, K G Franchini.   

Abstract

Studies have indicated a complex functional interaction between angiotensin (Ang) II and NO in the heart. The purpose of the present study was to examine the protein expression and tissue distribution of NO synthases 1 (NOS1) and 3 (NOS3) in the myocardium of rats that underwent continuous infusion of Ang II at 2 different rates (10 and 40 ng. kg(-1). min(-1)) for 6 days. Mean arterial pressure increased by approximately 15 mm Hg in rats infused with Ang II at 40 ng. kg(-1). min(-1), but it remained close to the values observed in saline-infused rats ( approximately 110 mm Hg) when Ang II was infused at 10 ng. kg(-1). min(-1). The protein expression of a 160-kDa NOS1 and a 135-kDa NOS3 were found to increase ( approximately 200%) in the myocardium of rats infused with both subpressor and pressor doses of Ang II. Immunohistochemistry studies showed that NOS1 and NOS3 are differentially expressed in myocardial cells. NOS1 was detected in cardiac myocytes and in smooth muscle cells of small and large coronary arteries, whereas NOS3 was detected in the endothelium and in perivascular and interstitial tissues, but NOS3 was not detected in cardiac or smooth muscle cells. Ang II infusion enhanced the tissue immunoreactivity of both isoforms in their specific locations but did not change the distribution throughout the myocardium. Myocardium staining with anti-angiotensin type 1 (AT(1)) receptor antibody indicated that AT(1) receptor is expressed in cardiac myocytes, coronary smooth muscle cells, and interstitial and perivascular tissues. Ang II infusion did not change the protein expression and distribution of AT(1) receptor in the myocardium. These results indicate that long-term increases in the circulating levels of Ang II modulate the protein expression of NOS1 and NOS3 and, consequently, the function of the local myocardial NO system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408389     DOI: 10.1161/01.hyp.37.6.1423

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology.

Authors:  Yin Hua Zhang; Chun Zi Jin; Ji Hyun Jang; Yue Wang
Journal:  J Physiol       Date:  2014-04-22       Impact factor: 5.182

2.  Angiotensin II-induced hypertension blunts thick ascending limb NO production by reducing NO synthase 3 expression and enhancing threonine 495 phosphorylation.

Authors:  Vanesa D Ramseyer; Agustin Gonzalez-Vicente; Oscar A Carretero; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-05

3.  ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes.

Authors:  Ji Hyun Jang; Jung Nyeo Chun; Shigeo Godo; Guangyu Wu; Hiroaki Shimokawa; Chun Zi Jin; Ju Hong Jeon; Sung Joon Kim; Zhe Hu Jin; Yin Hua Zhang
Journal:  Basic Res Cardiol       Date:  2015-03-25       Impact factor: 17.165

Review 4.  Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?

Authors:  Claire E Sears; Euan A Ashley; Barbara Casadei
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 5.  Neuronal nitric oxide synthase in hypertension - an update.

Authors:  Yin Hua Zhang
Journal:  Clin Hypertens       Date:  2016-11-03

6.  Angiotensin II stimulates superoxide production by nitric oxide synthase in thick ascending limbs.

Authors:  Agustin Gonzalez-Vicente; Jagannath H Saikumar; Katherine J Massey; Nancy J Hong; Fernando P Dominici; Oscar A Carretero; Jeffrey L Garvin
Journal:  Physiol Rep       Date:  2016-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.